Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
Recombinant factor concentrates may increase inhibitor development: a single centre cohort studyT Strauss, A Lubetsky, B Ravid, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Bone properties and muscle strength of young haemophilia patientsB Falk, S Portal, R Tiktinsky, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|March 24, 2000
Low cost locally prepared fibrin glue for clinical applications: reported of 145 cases. Committee of Bangkok International Hemophilia Training CenterP Isarangkura, P Chiewsilp, A Chuansumrit, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2011
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia AU Martinowitz, J Bjerre, B Brand, et al.
Bratislavske Lekarske Listy|February 11, 2015
Collection of peripheral hematopoietic stem/progenitor cellsV Rimajova Dihenescikova, M Mistrik, J Martinka, et al.
Bratislavske Lekarske Listy|August 23, 2016
Graft-versus-host disease managementM Mistrik, E Bojtarova, L Sopko, et al.
Journal of Medical Genetics|September 6, 2005
Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretionD Vu, P de Moerloose, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 26, 2009
Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis CY Maor, P Halfon, D Bashari, et al.
Thrombosis and Haemostasis|December 22, 2009
Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trialG Kenet, C B Stenmo, A Blemings, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2015
Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patientsU Martinowitz, T Lissitchkov, A Lubetsky, et al.
Pageof 15